Audrey Finesso

Audrey Finesso is a seasoned professional in clinical regulatory strategy and drug development, currently serving as Senior Director, Clinical Regulatory Strategist at Fortrea since January 2022. With extensive experience across various pharmaceutical and biotech companies, Audrey Finesso has led initiatives in clinical drug development, global regulatory affairs, and has expertise in US and EU territories, including orphan drug designations, pediatric plans, and diversity strategies. Prior roles include Senior Director at Labcorp Drug Development, Senior Manager at PregLem SA, and positions at Merck, Amgen, Biogen, and Johnson & Johnson. Audrey Finesso holds an MSc in International Drug Development and Registration from Paris-Sud University and a Pharm D from Université Claude Bernard Lyon 1.